New drug combo could replace chemo for rare blood cancer
Disease control
Recruiting now
This phase 2 trial is testing whether a combination of two drugs, venetoclax and rituximab, works better than standard chemotherapy for people with a rare blood cancer called Waldenström's macroglobulinemia who have not yet been treated. The study aims to see if this chemotherapy…
Phase: PHASE2 • Sponsor: Christian Buske • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC